Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mikael Dolsten
Age : 61
Public asset : 6,345,083 USD
Country of residence : Unknown
Linked companies : Pfizer Inc. - Vimian Group AB (publ) - Karyopharm Therapeutics Inc.

Biography of Mikael Dolsten 
Mikael Dolsten holds the position of Chief Scientific Officer & Research President at Pfizer Inc. Dr. Dolsten is also on the board of New York Academy of Sciences, Karyopharm Therapeutics, Inc. and PhRMA Foundation and Member of Royal Swedish Academy of Engineering Sciences and Member of Government-University-Industry Research Roundtable. In the past he occupied the position of Principal at OrbiMed Advisors LLC and Partner at OrbiMed Advisors Private Equity (a subsidiary of OrbiMed Advisors LLC), President for Wyeth Research, EVP, Global Head-Pharma Research & Discovery at Boehringer Ingelheim Pharmaceuticals, Inc., Senior Vice President for Wyeth Corp. and Member-Benefits, Law & Regulatory Committee at Wyeth Pharmaceuticals LLC. Dr. Dolsten received a doctorate from the University of Lund.


Current positions of Mikael Dolsten 
Holdings of Mikael Dolsten 
Mikael Dolsten : Personal Network 
Most Read News 
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Mikael Dolsten : Connections 


Latest news about Mikael Dolsten 
07/28MODERNA : Pfizer says 2021 COVID-19 vaccine sales to top $33.5 billion, sees need for boosters
RE
07/12MODERNA : Pfizer/BioNTech bid for booster doses premature, more data needed -experts
RE
07/09European Stocks Rebound, End Higher as Investors Look for Bargains
MT
07/09Today on Wall Street: Covid-19 derails recovery hopes
07/09BIONTECH : Pfizer, BioNTech to Seek US Approval for Booster COVID-19 Shot in August
MT
07/08Pfizer, BioNTech to seek authorization for COVID booster shot as Delta variant spreads
RE
07/08Pfizer to ask FDA to authorize booster dose of COVID vaccine as Delta variant spreads
RE
More news